David Middlemiss - Concepedia

Author

David Middlemiss

University of Hertfordshire

Also Known As

D Middlemiss, D. MIDDLEMISS, D. Middlemiss, David Middlemiss

Publications

1.4K

Citations

H-Index

Concepts

All Affiliations

University of Hertfordshire University of Strathclyde Dyson (United Kingdom)University of Oxford University of Stirling

About

David Middlemiss is an author at University of Hertfordshire specializing in chemistry, organic chemistry, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Engineering	12	12	451
2	Medicine	9	9	381
3	Natural Sciences	8	8	327
4	Public Health	1	1	85
5	Allergy	1	1	48

David Middlemiss

Publications

1.2K

Citations

H-Index

Page 1

	Year	Citations
A convenient procedure for the solution phase preparation of 2-aminothiazole combinatorial libraries Nicholas Bailey, Anthony Dean, Duncan B. Judd, Bioorganic & Medicinal Chemistry Letters Combinatorial ChemistryMedicinal ChemistrySolution Phase PreparationBioorganic ChemistryBiochemistry	1996	98
Highly Efficient Enantioselective Pauson-Khand Reactions Alistair M. Hay, William J. Kerr, George Kirk, Organometallics EngineeringOccupational Health SciencesAltmetric Attention ScoreBibliometricsChemistry	1995	85
Pharmacological profile of GR117289 <i>in vitro</i>: a novel, potent and specific non‐peptide angiotensin AT<sub>1</sub> receptor antagonist Mark J. Robertson, Jen Barnes, G.M. Drew, British Journal of Pharmacology	1992	76
Absolute configuration of the optical isomers of salbutamol D. HARTLEY, David Middlemiss Journal of Medicinal Chemistry AltmetricsPhotonicsOptical MaterialsEngineeringOptical Properties	1971	69
Enantioselective Pauson-Khand Reactions Mediated by a Chiral Amine N-Oxide William J. Kerr, George Kirk, David Middlemiss Synlett Asymmetric VersionHeterocyclicOrganic ChemistryChiral Amine N-oxideStereoselective Synthesis	1995	56
A medicinal chemistry case study: An account of an angiotensin II antagonist drug discovery programme David Middlemiss, Steve P. Watson Tetrahedron Medicinal ChemistryPharmacological StudyMedicineRational Drug DesignPharmacotherapy	1994	55
Promotion of the chromium carbene Dötz annulation reaction under sonochemical and dry state adsorption conditions Joseph P. A. Harrity, William J. Kerr, David Middlemiss Tetrahedron Materials ScienceInorganic ChemistryChemical EngineeringEngineeringChemisorption	1993	54
Discovery of an Orally Bioavailable NK1 Receptor Antagonist, (2S,3S)-(2-Methoxy-5-tetrazol-1-ylbenzyl)(2-phenylpiperidin-3-yl)amine (GR203040), with Potent Antiemetic Activity P. Ward, Duncan Armour, David E. Bays, Journal of Medicinal Chemistry Potent Antiemetic ActivityMedicinal ChemistryMethyl SulfoneMetabolic ProfilePharmacological Study	1995	52
Bromobenzofurans : a new class of potent, non-peptide antagonists of angiotensin II David Middlemiss, G.M. Drew, Barry C. Ross, Bioorganic & Medicinal Chemistry Letters Molecular PharmacologyMedicinal ChemistryAngiotensin IiAntiparasitic AgentPharmacology	1991	50
Indole-3-acetic Acid Antagonists of the Prostaglandin D<sub>2</sub> Receptor CRTH2 Richard Armer, Mark Ashton, Edward A. Boyd, Journal of Medicinal Chemistry Indole-3-acetic Acid AntagonistsCrth2 ReceptorImmunologyPharmacotherapyHypersensitivity	2005	48

Page 1